|What TRUVADA looks like|
The drug has been examined for use as a pre-exposure prophylaxis (PrEP) against HIV infection. A Cochrane review found that both tenofovir alone, as well as the tenofovir/emtricitabine combination, significantly decreased the risk of contracting HIV. The Food and Drug Administration approved it for prophylactic use on July 16, 2012. Truvada was developed by Gilead Sciences and approved by the United States Food and Drug Administration in 2004.
In certain studies, the drug has demonstrated rare side effects including: nausea, vomiting, dizziness, loss of appetite and diarrhea, liver and kidney toxicity and loss of bone density.
HOWEVER there are drawbacks to this kind of medication.
Since it is an ARV the drug needs to be taken at a specific time of the day.
This would encourage unsafe sex practices since they would be relying on the drug.
This drugs is expensive and the government might not have enough budget to purchase it.
This drug can pose serious side effects and considering it is given to healthy individuals.
IN THE END,
PREVENTION IS STILL BETTER THAN CUREHealthcare Workers can provide options for the people who want to access the drug but also they need to remind them that still the safe way to avoid HIV and other Sexually Transmitted Infection is to avoid doing risky behaviors and follow the ABC's of PREVENTION.
Be faithful / Mutual Monogamous Relationship between non-infected partners
Correct & Consistent Condom Use
Don’t use shared needles or syringes / abuse drugs and alcohol
Education / Early Detection & Treatment of Sexually Transmitted Infections
Again This is JaKe Positive. BE SAFE! +)